JT is committed to the research and development of world-class, innovative drugs.
Our pharmaceutical business aims to create innovative, original drugs to support patients in the shortest time possible.
As this business has a direct impact on human health and life, we not only strictly comply with all laws, regulations, and industry standards, but are also guided by a strong sense of ethics and responsibility. This is particularly the case in areas such as clinical trials and promoting drugs, as well as animal experiments and managing chemical substances.
JT concentrates on R&D, while Torii Pharmaceutical Co., Ltd. is in charge of manufacturing, sales, and promotion in the Japanese domestic market. Outside of Japan, we do not have a sales function, but we do license drugs to other pharmaceutical manufacturers.
Our pharmaceutical business value chain *
- * This diagram represents the value chain of products manufactured and/or developed by JT, and sold and promoted by Torii Pharmaceutical
Sustainability strategy of our pharmaceutical business
Throughout 2019, our pharmaceutical business held numerous discussions on sustainability and set out three focus areas. The mission of the pharmaceuticals business is to create innovative, original drugs to support patients in the shortest time possible. In view of this mission, we have selected "products and services" and "product safety and responsibility" as our first and second focus areas. As talent development of our employees is essential to first-in-class drug discovery, we have selected "people" as the third focus area. In total, we have set five specific targets for these pharmaceutical business focus areas.
These will provide a solid basis for measuring and benchmarking our sustainability performance, and support the sustainability of the JT Group. We will be updating our progress regularly, as we strive to contribute and fulfill our commitments that we have made to our stakeholders and to ourselves.
Pharmaceuticals and sustainability
The mission of our pharmaceutical business is to create innovative, original drugs to support patients in the shortest time possible.